A randomised Trial of Autologous Blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in LEprosy: The TABLE trial
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012088 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Indra B Napit und 11 weiteren Autor:innen. Beteiligte Einrichtung: Anandaban Hospital, The Leprosy Mission Nepal, Kathmandu, Nepal. Hauptthemen laut MEDLINE: Leprosy, Wound Healing, Platelet-Rich Fibrin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR ARC West Midlands, NIHR Senior Investigator, UK Department of Health and Social Care.
Abstract (Originalsprache)
Introduction
Autologous blood products like Platelet Rich Plasma (PRP) and Leukocyte and Platelets Rich Fibrin (L-PRF) have been used for many years across many types of skin ulcers. However, the effectiveness of autologous blood products on wound healing is not well established.
Methods
We evaluated the ‘second generation’ autologous product- Leukocyte and Platelet- Rich Fibrin (L-PRF). Our trial was undertaken on patients suffering from neuropathic leprosy ulcers at the Anandaban hospital which serves the entire country of Nepal. We conducted a 1:1 (n = 130) individually randomised trial of L-PRF (intervention) vs. normal saline dressing (control) to compare rate of healing and time to complete healing. Rate of healing was estimated using blind assessments of ulcer areas based on three different measurement methods. Time to complete healing was measured by the local unblinded clinicians and by blind assessment of ulcer images.
Results
The point estimates for both outcomes were favourable to L-PRF but the effect sizes were small. Unadjusted mean differences (intervention vs control) in mean daily healing rates (cm 2 ) were respectively 0.012 (95% confidence interval 0.001 to 0.023, p = 0.027); 0.016 (0.004 to 0.027, p = 0.008) and 0.005 (-0.005 to 0.016, p = 0.313) across the three measurement methods. Time to complete healing at 42 days yielded Hazard Ratios (unadjusted) of 1.3 (0.8 to 2.1, p = 0.300) assessed by unblinded local clinicians and 1.2 (0.7 to 2.0, p = 0.462) on blind assessment.
Conclusion
Any benefit from L-PRF appears insufficient to justify routine use in care of neuropathic ulcers in leprosy.
Trial registration
ISRCTN14933421 . Date of trial registration: 16 June 2020.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Anandaban Hospital, The Leprosy Mission Nepal, Kathmandu, Nepal.
- Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
- Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
- Birmingham Clinical Trials Unit, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
ORCID-Profile: Indra B Napit
Förderung
- NIHR ARC West Midlands
- NIHR Senior Investigator
- UK Department of Health and Social Care
- National Institute for Health and Care Research
Zitieren
APA
Napit, I. B., Shrestha, D., Choudhury, S., Gkini, E., Ilozumba, O., Gill, P., Bishop, J., Neupane, K., Adhikari, A., Sartori, J., Watson, S. I., & Lilford, R. (2024). A randomised Trial of Autologous Blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in LEprosy: The TABLE trial. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012088
Vancouver
Napit IB, Shrestha D, Choudhury S, Gkini E, Ilozumba O, Gill P, et al. A randomised Trial of Autologous Blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in LEprosy: The TABLE trial. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012088
BibTeX
@article{Napit2024,
author = {Napit, Indra B and Shrestha, Dilip and Choudhury, Sopna and Gkini, Eleni and Ilozumba, Onaedo and Gill, Paramjit and Bishop, Jon and Neupane, Karuna and Adhikari, Anju and Sartori, Jo and Watson, Samuel I and Lilford, Richard},
title = {A randomised Trial of Autologous Blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in LEprosy: The TABLE trial},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012088}
}
EUVIMED